EXAS
Exact Sciences Corp
Price:  
48.36 
USD
Volume:  
2,240,499.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXAS Relative Valuation

-290.9%
Upside

As of 2025-07-22, the Relative Valuation of Exact Sciences Corp (EXAS) is (92.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 48.36 USD, the upside of Exact Sciences Corp based on Relative Valuation is -290.9%.

The range of the Relative Valuation is (66.71) - (115.05) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 12.3x - 21.4x 18.5x
Forward P/E multiples 9.9x - 21.3x 15.6x
Fair Price (66.71) - (115.05) (92.31)
Upside -238.0% - -337.9% -290.9%
48.36 USD
Stock Price
(92.31) USD
Fair Price

EXAS Relative Valuation - Historical P/E Data

Date P/E
2025-07-21 -9.24
2025-07-18 -9.33
2025-07-17 -9.66
2025-07-16 -9.93
2025-07-15 -9.80
2025-07-14 -10.04
2025-07-11 -9.60
2025-07-10 -9.86
2025-07-09 -10.23
2025-07-08 -9.90
2025-07-07 -9.71
2025-07-03 -9.87
2025-07-02 -9.96
2025-07-01 -10.10
2025-06-30 -9.83
2025-06-27 -9.92
2025-06-26 -9.58
2025-06-25 -9.60
2025-06-24 -9.46
2025-06-23 -9.72
2025-06-20 -9.81
2025-06-18 -9.68
2025-06-17 -9.72
2025-06-16 -9.86
2025-06-13 -9.90
2025-06-12 -9.99
2025-06-11 -10.30
2025-06-10 -10.39
2025-06-09 -10.10
2025-06-06 -10.15
2025-06-05 -10.06
2025-06-04 -10.20
2025-06-03 -10.14
2025-06-02 -10.38
2025-05-30 -10.41
2025-05-29 -10.66
2025-05-28 -10.74
2025-05-27 -10.46
2025-05-23 -10.53
2025-05-22 -10.45
2025-05-21 -10.52
2025-05-20 -10.69
2025-05-19 -10.53
2025-05-16 -10.44
2025-05-15 -10.39
2025-05-14 -10.15
2025-05-13 -9.93
2025-05-12 -9.88
2025-05-09 -9.55
2025-05-08 -9.81